Skip to main content
Clinical Trials/NL-OMON51353
NL-OMON51353
Completed
Phase 4

Multiparameter vital signs monitoring validation of the Corsano CardioWatch 287-2 - MULTI-VITA

Corsano Health B.V.0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Corsano Health B.V.
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Corsano Health B.V.

Eligibility Criteria

Inclusion Criteria

  • \>\= 18 years old;
  • undergoing invasive monitoring, like coronary angiography;
  • able to provide consent.

Exclusion Criteria

  • who cannot wear the Corsano CardioWatch 287 due to reasons such as allergic
  • reactions, wounds, amputations etc.;
  • unable or not willing to sign informed consent;
  • with significant mental or cognitive impairment;
  • who do not have a suitable entry site for the invasive arterial line.

Outcomes

Primary Outcomes

Not specified

Similar Trials